Literature DB >> 24129163

Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation.

R E Vandenbroucke1, I Vanlaere1, F Van Hauwermeiren1, E Van Wonterghem1, C Wilson2, C Libert1.   

Abstract

Matrix metalloproteinase 7 (MMP7) is a member of the MMP family. In the small intestine, MMP7 is responsible for activating α-defensins, which are broad-spectrum anti-microbial peptides produced by the Paneth cells. We report that MMP7(-/-) mice are resistant to LPS-induced lethality and that this resistance is correlated with reduced levels of systemic cytokines. LPS induced the upregulation and activation of MMP7 in the small intestine, degranulation of the Paneth cells, and induction of intestinal permeability in MMP7(+/+) mice. In MMP7(-/-) mice, both LPS-induced intestinal permeability and consequent bacterial translocation to the mesenteric lymph nodes were reduced. Based on gene expression analysis and evaluation of intestinal damage, we attribute the protected state of MMP7(-/-) mice to reduced intestinal inflammation. Interestingly, we found that different α-defensins, namely Crp1 (DEFA1) and Crp4 (DEFA4), can stimulate IL-6 release in macrophages and ileum explants in a TLR4 independent way. We conclude that absence of MMP7 protects mice from LPS-induced intestinal permeability and lethality, and suggest that MMP7-activated α-defensins, in addition to their previously recognized bactericidal and anti-inflammatory roles, may exhibit pro-inflammatory activities in the intestine by activating macrophages and amplifying the local inflammatory response in the gut, leading to intestinal leakage and subsequent increase in systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24129163     DOI: 10.1038/mi.2013.76

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  53 in total

Review 1.  Paneth cell defensins and innate immunity of the small bowel.

Authors:  A J Ouellette; C L Bevins
Journal:  Inflamm Bowel Dis       Date:  2001-02       Impact factor: 5.325

2.  Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis.

Authors:  Timo Rath; Martin Roderfeld; Jörg Michael Halwe; Annette Tschuschner; Elke Roeb; Jürgen Graf
Journal:  Scand J Gastroenterol       Date:  2010-10       Impact factor: 2.423

3.  The effect of epidermal growth factor on the septic complications of acute pancreatitis.

Authors:  Q Liu; G Djuricin; C Nathan; P Gattuso; R A Weinstein; R A Prinz
Journal:  J Surg Res       Date:  1997-04       Impact factor: 2.192

Review 4.  Gut failure in the ICU.

Authors:  Francesco Puleo; Marianna Arvanitakis; André Van Gossum; Jean-Charles Preiser
Journal:  Semin Respir Crit Care Med       Date:  2011-10-11       Impact factor: 3.119

5.  Attenuation of internal organ damages by exogenously administered epidermal growth factor (EGF) in burned rodents.

Authors:  Jorge Berlanga; Jorge Lodos; Pedro López-Saura
Journal:  Burns       Date:  2002-08       Impact factor: 2.744

6.  Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.

Authors:  Dinna N Cruz; Massimo Antonelli; Roberto Fumagalli; Francesca Foltran; Nicola Brienza; Abele Donati; Vincenzo Malcangi; Flavia Petrini; Giada Volta; Franco M Bobbio Pallavicini; Federica Rottoli; Francesco Giunta; Claudio Ronco
Journal:  JAMA       Date:  2009-06-17       Impact factor: 56.272

7.  Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis.

Authors:  Jessica A Clark; Andrew T Clark; Richard S Hotchkiss; Timothy G Buchman; Craig M Coopersmith
Journal:  Shock       Date:  2008-07       Impact factor: 3.454

8.  Bacterial exposure induces and activates matrilysin in mucosal epithelial cells.

Authors:  Y S López-Boado; C L Wilson; L V Hooper; J I Gordon; S J Hultgren; W C Parks
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

9.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

10.  Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors.

Authors:  Vincenzo Cantaluppi; Barbara Assenzio; Daniela Pasero; Giuseppe Mauriello Romanazzi; Alfonso Pacitti; Giacomo Lanfranco; Valeria Puntorieri; Erica L Martin; Luciana Mascia; Gianpaola Monti; Giampaolo Casella; Giuseppe Paolo Segoloni; Giovanni Camussi; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2008-05-08       Impact factor: 17.440

View more
  34 in total

1.  TNFR1-induced lethal inflammation is mediated by goblet and Paneth cell dysfunction.

Authors:  F Van Hauwermeiren; R E Vandenbroucke; L Grine; S Lodens; E Van Wonterghem; R De Rycke; N De Geest; B Hassan; C Libert
Journal:  Mucosal Immunol       Date:  2014-11-26       Impact factor: 7.313

Review 2.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

3.  Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice.

Authors:  Tom Vanden Berghe; Paco Hulpiau; Liesbet Martens; Roosmarijn E Vandenbroucke; Elien Van Wonterghem; Seth W Perry; Inge Bruggeman; Tatyana Divert; Sze Men Choi; Marnik Vuylsteke; Valery I Shestopalov; Claude Libert; Peter Vandenabeele
Journal:  Immunity       Date:  2015-07-07       Impact factor: 31.745

4.  Matrix metalloproteinase-7 protects against acute kidney injury by priming renal tubules for survival and regeneration.

Authors:  Haiyan Fu; Dong Zhou; Haili Zhu; Jinlin Liao; Lin Lin; Xue Hong; Fan Fan Hou; Youhua Liu
Journal:  Kidney Int       Date:  2019-03-08       Impact factor: 10.612

5.  Synthesis and Validation of a Hydroxypyrone-Based, Potent, and Specific Matrix Metalloproteinase-12 Inhibitor with Anti-Inflammatory Activity In Vitro and In Vivo.

Authors:  J Aerts; R E Vandenbroucke; R Dera; S Balusu; E Van Wonterghem; L Moons; C Libert; W Dehaen; L Arckens
Journal:  Mediators Inflamm       Date:  2015-08-13       Impact factor: 4.711

6.  Mice overexpressing β-1,4-Galactosyltransferase I are resistant to TNF-induced inflammation and DSS-induced colitis.

Authors:  Valerie Vanhooren; Roosmarijn E Vandenbroucke; Sylviane Dewaele; Evelien Van Hamme; Jody J Haigh; Tino Hochepied; Claude Libert
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

7.  Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.

Authors:  Ines Ambite; Manoj Puthia; Karoly Nagy; Caterina Cafaro; Aftab Nadeem; Daniel S C Butler; Gustav Rydström; Nina A Filenko; Björn Wullt; Thomas Miethke; Catharina Svanborg
Journal:  PLoS Pathog       Date:  2016-10-12       Impact factor: 6.823

8.  Gene expression profiling in non-human primate jejunum, ileum and colon after total-body irradiation: a comparative study of segment-specific molecular and cellular responses.

Authors:  Junying Zheng; Junru Wang; Mylene Pouliot; Simon Authier; Daohong Zhou; David S Loose; Martin Hauer-Jensen
Journal:  BMC Genomics       Date:  2015-11-21       Impact factor: 3.969

Review 9.  Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.

Authors:  Marjana Brkic; Sriram Balusu; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Mediators Inflamm       Date:  2015-10-11       Impact factor: 4.711

10.  Sizing nanomaterials in bio-fluids by cFRAP enables protein aggregation measurements and diagnosis of bio-barrier permeability.

Authors:  Ranhua Xiong; Roosmarijn E Vandenbroucke; Katleen Broos; Toon Brans; Elien Van Wonterghem; Claude Libert; Jo Demeester; Stefaan C De Smedt; Kevin Braeckmans
Journal:  Nat Commun       Date:  2016-09-22       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.